Connacht Asset Management’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-20,953
| Closed | -$170K | – | 83 |
|
|
2022
Q2 | $170K | Buy |
20,953
+4,788
| +30% | +$38.8K | 0.07% | 92 |
|
|
2022
Q1 | $273K | Buy |
16,165
+5,841
| +57% | +$98.6K | 0.14% | 77 |
|
|
2021
Q4 | $222K | Buy |
10,324
+134
| +1% | +$2.88K | 0.22% | 85 |
|
|
2021
Q3 | $753K | Sell |
10,190
-6,494
| -39% | -$480K | 0.49% | 35 |
|
|
2021
Q2 | $912K | Buy |
+16,684
| New | +$912K | 0.39% | 49 |
|